July 22, 2013
Otsuka Pharmaceutical announced on July 17 that the Alzheimer’s disease (AD) treatment Lu AE58054 as an add-on therapy to donepezil demonstrated in a PII study significant cognitive performance improvement in AD patients compared to placebo. Lu AE58054 is a selective...read more